EDESA BIOTECH, INC. Embedded Derivative, Fair Value of Embedded Derivative Liability
EDESA BIOTECH, INC. (EDSA) had Embedded Derivative, Fair Value of Embedded Derivative Liability of $5.35 million as of 2014-08-31, per its 10-K filed 2014-11-21.
Discontinued › Notes
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability · last filed 2015-02-09
- 2014-08-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $5.35M.
- 2013-09-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $8.89M.
- 2013-08-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $6.84M.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative Liability |
|---|---|
| 2014-08-31 | $5.35M 10-K · filed 2014-11-21 |
| 2013-09-30 | $8.89M 10-Q · filed 2015-02-09 |
| 2013-08-31 | $6.84M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |